EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Design, Synthesis, In Silico Studies, and HIV‐1 RT Inhibitory Activity of 1,3‐Oxazolidine Pyrimidine Nucleoside Analogues

Shimoga Nagaraj Sriharsha, Zaid Mahmood Mohamed iD, Ammar A Razzak Mahmood iD, Sibghatullah Muhammad Ali Sangi, Sadik Shaik iD, Sreeharsha Nagaraja iD, Sheeba Kumari, Vidhya Thirunavukkarasu iD, Pavan Kumar Sreenivasalu, Monirul Islam iD, Muhammad Shahzad Chohan, Mahalakshmi Suresha Biradar iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Shimoga Nagaraj Sriharsha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, National College of Pharmacy, Shimoga, India. Hauptthemen laut MEDLINE: Reverse Transcriptase Inhibitors, HIV Reverse Transcriptase, Oxazoles, Drug Design. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 1,3‐oxazolidine nucleoside analogues (1‐6) was designed and synthesized for their anti‐HIV activity. The purpose of this study was to determine whether the antiviral activity of the pyrimidine ring is affected by oxazolidine ring substitution. The synthesized compounds were tested for their HIV‐1 RT inhibitory activity by a colorimetric HIV reverse transcriptase (HIVRT) test. The fluoro ( S4 ) and bromo ( S5 ) derivatives of these compounds showed the highest HIV‐1 reverse transcriptase IC 50 values, 19.27 and 22.80 µM, respectively. Modest activity was observed for the remaining compounds. The molecular docking experiments with the crystal structure of HIV‐1 reverse transcriptase (PDB ID: 1RT1) revealed that S4 and S5 have good binding affinities of −7.6 and −7.3 kcal/mol, respectively, with multiple hydrogen bonds and π‐interactions with key residues in the active site. The properties of all the synthesized compounds were found to be in accordance with Lipinski Rule of Five and showed a favorable ADME profile, indicating good drug‐likeness, acceptable solubility, and potential oral bioavailability. Halogen substitution enhances electronic dispersion and hydrophobic interactions, but the oxazolidine scaffold is superior to thiazolidine scaffolds. Halogenated oxazolidine compounds are generally promising HIV‐1 reverse transcriptase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reverse Transcriptase InhibitorsHIV Reverse TranscriptaseOxazolesDrug DesignAnti-HIV AgentsHIV-1Pyrimidine NucleosidesMolecular Docking SimulationStructure-Activity RelationshipHumansMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

1,3‐oxazolidineanti‐HIVdockingnucleosidesynthesis

Substanzen

Reverse Transcriptase InhibitorsHIV Reverse TranscriptaseOxazolesAnti-HIV Agentsoxazolidinereverse transcriptase, Human immunodeficiency virus 1Pyrimidine Nucleosides

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, National College of Pharmacy, Shimoga, India.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Al-Zahraa University for Women, Karbala, Iraq.
  • Department of Pharmacy, Al Ma'moon University, 14-Ramadan Street, Baghdad, Iraq.
  • Basic Medical Sciences Department, Dar Al Uloom University, Riyadh, Saudi Arabia.
  • Department of Pharmacology, Anuradha College of Pharmacy, Bengaluru, India.
  • Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.

ORCID-Profile: Zaid Mahmood Mohamed, Ammar A Razzak Mahmood, Sadik Shaik, Sreeharsha Nagaraja, Vidhya Thirunavukkarasu, Monirul Islam, Mahalakshmi Suresha Biradar

Förderung

  • Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia

Zitieren

APA

Sriharsha, S. N., Mohamed, Z. M., Mahmood, A. A. R., Sangi, S. M. A., Shaik, S., Nagaraja, S., Kumari, S., Thirunavukkarasu, V., Sreenivasalu, P. K., Islam, M., Chohan, M. S., & Biradar, M. S. (2026). Design, Synthesis, In Silico Studies, and HIV‐1 RT Inhibitory Activity of 1,3‐Oxazolidine Pyrimidine Nucleoside Analogues. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71638

Vancouver

Sriharsha SN, Mohamed ZM, Mahmood AAR, Sangi SMA, Shaik S, Nagaraja S, et al. Design, Synthesis, In Silico Studies, and HIV‐1 RT Inhibitory Activity of 1,3‐Oxazolidine Pyrimidine Nucleoside Analogues. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71638

BibTeX
@article{Sriharsha2026,
  author = {Sriharsha, Shimoga Nagaraj and Mohamed, Zaid Mahmood and Mahmood, Ammar A Razzak and Sangi, Sibghatullah Muhammad Ali and Shaik, Sadik and Nagaraja, Sreeharsha and Kumari, Sheeba and Thirunavukkarasu, Vidhya and Sreenivasalu, Pavan Kumar and Islam, Monirul and Chohan, Muhammad Shahzad and Biradar, Mahalakshmi Suresha},
  title = {Design, Synthesis, In Silico Studies, and HIV‐1 RT Inhibitory Activity of 1,3‐Oxazolidine Pyrimidine Nucleoside Analogues},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71638}
}
Kostenlos starten →